Share on LinkedInShare on LinkedIn

ARTICLE · 10 JANUARY 2012

OSC Reviewing Oversight Of Poison Pills And Rules For Related Party Transactions

Blake, Cassels & Graydon LLP
Blake, Cassels & Graydon LLP
Contributor
Blake, Cassels & Graydon LLP

Blake, Cassels & Graydon LLP

As one of Canada’s top business law firms, Blake, Cassels & Graydon LLP (Blakes) provides...

View firm profile
Explore more from Blake, Cassels & Graydon LLP

In a recent public forum addressing current developments in Canadian securities law, the deputy director of the Ontario Securities Commission indicated that OSC staff is considering proposing two significant regulatory changes relevant to Canadian M&A transactions.

CanadaFinance and Banking

Copyright 2012, Blake, Cassels & Graydon LLP

Originally published in Blakes Bulletin on Mergers & Acquisitions, January 2012

In a recent public forum addressing current developments in Canadian securities law, the deputy director of the Ontario Securities Commission indicated that OSC staff is considering proposing two significant regulatory changes relevant to Canadian M&A transactions.

The first proposal would permit a target board to employ a shareholder rights plan (poison pill), which has been approved by the target's shareholders, to defend indefinitely against an unsolicited take-over bid, extending a view espoused by the OSC and the Alberta Securities Commission in certain recent poison pill decisions.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from